As of Apr 24
| -0.005 / -0.64%|
The 1 analysts offering 12-month price forecasts for LifeVantage Corp have a median target of 1.30, with a high estimate of 1.30 and a low estimate of 1.30. The median estimate represents a +67.74% increase from the last price of 0.78.
The current consensus among 1 polled investment analysts is to Hold stock in LifeVantage Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.